GlassScriptPhysician profile
Jason G Anderson
NPI 1134235930
$12,379.81
in general payments reported to CMS, 2019-2025
18 companies · $1,846 in 2025
The $1,846 reported for 2025 was more than what 84% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,189 · 2020: $485 · 2021: $514 · 2022: $2,110 · 2023: $3,241 · 2024: $1,994 · 2025: $1,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,532 · Travel and Lodging: $3,004 · Consulting Fee: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,532.48 |
| Travel and Lodging | $3,003.70 |
| Consulting Fee | $545.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $3,401.59 | 2023-2025 | Reactiv8 |
| Abbott Laboratories | $1,754.87 | 2019-2025 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $1,313.19 | 2022 | |
| Si-Bone, INC. | $987.77 | 2024 | |
| Vertiflex, INC. | $812.86 | 2019 | |
| Vertos Medical, INC. | $759.04 | 2019 | |
| Saluda Medical Americas, INC. | $740.99 | 2022-2025 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $683.42 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $574.96 | 2019-2025 | General - Pain Management, General - Therapies |
| Spr Therapeutics, INC | $414.58 | 2022-2023 | Sprint Pns System |
| Axonics, INC. | $275.44 | 2022-2024 | Axonics |
| Painteq LLC | $258.44 | 2021-2022 | |
| Nevro Corp. | $242.28 | 2019-2024 | Senza |
| Nalu Medical, INC. | $53.70 | 2022-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $38.04 | 2022-2025 | Inceptiv |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $33.06 | 2021 | |
| Globus Medical, INC. | $23.58 | 2025 | Vyrsa V1 |
| Stimwave Technologies Incorporated | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.